Literature DB >> 8832584

The opposite effects of amitriptyline on noradrenaline- and methoxamine-evoked venoconstriction in man.

A H Abdelmawla1, R W Langley, E Szabadi, C M Bradshaw.   

Abstract

The effects of a single oral dose (100 mg) of amitriptyline on noradrenaline- and methoxamine-evoked venoconstriction were compared, using the dorsal hand vein compliance technique, in 8 healthy male volunteers. Both noradrenaline and methoxamine produced dose-dependent venoconstriction; the geometric mean ED50 for noradrenaline was 4.15 ng min-1 and for methoxamine was 1143.54 ng min-1; the potency ratio (noradrenaline/methoxamine) was 277. Amitriptyline shifted the dose-response curve for noradrenaline to the left (ANOVA: P < 0.025; dose-ratio: 0.38) consistent with potentiation, and the dose-response curve for methoxamine to the right (ANOVA: P < 0.025; dose ratio: 2.72) consistent with antagonism. The potentiation is likely to be due to noradrenaline uptake blockade, whereas the antagonism is likely to reflect the blockade of post-junctional alpha 1-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8832584     DOI: 10.1007/bf00168702

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  28 in total

1.  Statistical estimations in enzyme kinetics.

Authors:  G N WILKINSON
Journal:  Biochem J       Date:  1961-08       Impact factor: 3.857

2.  The potassium channel opening drug cromakalim produces arterioselective vasodilation in the upper limbs of healthy volunteers.

Authors:  D J Webb; N Benjamin; P Vallance
Journal:  Br J Clin Pharmacol       Date:  1989-06       Impact factor: 4.335

3.  A comparison of the effect of paroxetine and amitriptyline on the tyramine pressor response test.

Authors:  S M Hassan; G Wainscott; P Turner
Journal:  Br J Clin Pharmacol       Date:  1985-05       Impact factor: 4.335

4.  Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro.

Authors:  E Richelson; A Nelson
Journal:  J Pharmacol Exp Ther       Date:  1984-07       Impact factor: 4.030

5.  Interaction of desipramine and amitriptyline with adrenergic mechanisms in the human iris in vivo.

Authors:  E Szabadi; P Gaszner; C M Bradshaw
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

6.  A model of two functionally antagonistic receptor populations activated by the same agonist.

Authors:  E Szabadi
Journal:  J Theor Biol       Date:  1977-11-07       Impact factor: 2.691

7.  The effect of oral cilazapril and prazosin on the constrictor effects of locally infused angiotensin I and noradrenaline in human dorsal hand veins.

Authors:  G G Belz; C Beermann; J Schloos; C H Kleinbloesem
Journal:  Br J Clin Pharmacol       Date:  1989-11       Impact factor: 4.335

8.  Comparison of the effects of desipramine on noradrenaline- and methoxamine-evoked venoconstriction in man.

Authors:  A H Abdelmawla; R W Langley; E Szabadi; C M Bradshaw
Journal:  Br J Clin Pharmacol       Date:  1995-11       Impact factor: 4.335

9.  Binding of antidepressants to human brain receptors: focus on newer generation compounds.

Authors:  B Cusack; A Nelson; E Richelson
Journal:  Psychopharmacology (Berl)       Date:  1994-05       Impact factor: 4.530

10.  H1- and H2-histamine receptor-mediated vasodilation varies with aging in humans.

Authors:  G Bedarida; E Bushell; T F Blaschke; B B Hoffman
Journal:  Clin Pharmacol Ther       Date:  1995-07       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.